Kiliana Suzart‐Woischnik

机构：Bayer (Germany) · ORCID：0000-0002-3189-6378

发表论文 54 篇 · 总被引 788 次 · h-index 14

代表论文

• Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis (2022 · Heart · 被引 54)
• Generalizability of randomized controlled trials in heart failure with reduced ejection fraction (2021 · European Heart Journal - Quality of Care and Clinical Outcomes · 被引 37)
• Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden (2020 · Therapeutic Advances in Neurological Disorders · 被引 34)
• The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis (2019 · PLoS ONE · 被引 18)
• Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden (2020 · Multiple Sclerosis and Related Disorders · 被引 16)
• Identification and Mapping Real-World Data Sources for Heart Failure, Acute Coronary Syndrome, and Atrial Fibrillation (2021 · Cardiology · 被引 15)